Why the study?
Does sub-maximal exercise stress echocardiography identify myocardial dysfunction in patients with HFpEF compared to healthy controls?
Does sub-maximal exercise stress echocardiography identify myocardial dysfunction in patients with HFpEF compared to healthy controls?
Sub-maximal exercise stress echocardiography reveals significant impairments in LV and RV longitudinal function in HFpEF patients compared to controls, highlighting its potential diagnostic utility.
Answers are grounded in this paper and cite their sources.
May unmask LV/RV dysfunction in HFpEF during sub-maximal exercise; hypothesis-generating and should not yet change practice.
BACKGROUND: Heart failure (HF) with a preserved (P) left ventricular (LV) ejection fraction (EF) is common, though its diagnosis and physiopathology remains unclear. We sought to analyse the myocardial characteristics at rest and during a sub-maximal exercise test in patients with HFPEF. METHODS AND RESULTS: Standardized sub-maximal exercise stress echocardiography was performed in (i) 21 patients from the Karolinska Rennes Prospective Study of Heart Failure with Preserved Left Ventricular Ejection Fraction HFPEF registry, whose LVEF was ≥45% and (ii) 15 control patients free of any manifestations of HF. During a sub-maximal exercise test, LV systolic function measured as a global four-chamber longitudinal strain was -17±5% in patients with HFPEF vs. -22±4% in controls (P<0.001), LV longitudinal diastolic relaxation, expressed as e' (septal and lateral walls averaged) was 9±2 cm/s in patients vs. 15±4 cm/s in controls (P<0.001), and RV longitudinal systolic function, expressed as RV s', was 14±3 cm/s in patients vs. 18±1 cm/s in controls (P=0.03). LV afterload (arterial elastance) was 2.7±1 mmHg/mL and was correlated with a decrease in LV longitudinal strain (R=0.51, P<0.01) during exercise. CONCLUSION: The assessment of longitudinal systolic and diastolic LV and RV functions is valuable during a sub-maximal exercise stress echocardiography to confirm the heart dysfunction related to the HFPEF symptoms. It might be used as a diagnostic test for difficult clinical situations. ClinicalTrials.gov identifier: NCT01091467.
No takes yet. Share an insight, caveat, or question.
Donal et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: